13F filerCIK 1061768 ↗
Baupost Group
You are looking at Q4 2023. See the latest, Q3 2026 →
Reported value
$4.59B
−12% on the quarter before
Positions
23
2 new, 11 sold out
Top 10
83.6%
of the value
Est. gain
+$520.2M
on stocks held all quarter
Est. return
+16.9%
on those stocks since Q3 2023
Positions as of Dec 31, 2023, from Baupost Group's 13F filing with the SEC. A 13F lists a manager's US-listed stocks and options at a quarter end and is filed up to 45 days later, so the fund may hold something else today. It leaves out short positions, cash and holdings outside the US.
Portfolio at a glance
- New
- Added
- Cut
- Same
- Options
Each tile is a position, sized by its share, colored by what the fund did with it since Q3 2023. Striped tiles are options.
Largest buys
Since Q3 2023, sized at quarter-end prices.
- Liberty Global Ltd~$788.7MNew, 0.0% → 17.2% of the portfolio+42,311,011 shares
- Liberty Global Ltd~$127.8MNew, 0.0% → 2.8% of the portfolio+7,194,276 shares
- Jacobs Solutions Inc~$31.2MAdded, 1.3% → 2.1% of the portfolio+240,000 shares
- Clarivate Plc~$27.8MAdded, 2.9% → 5.2% of the portfolio+3,000,000 shares
- Jazz Pharmaceuticals Plc~$19.7MAdded, 1.7% → 2.2% of the portfolio+160,000 shares
Largest sells
Since Q3 2023, sized at quarter-end prices.
- Liberty Global Plc~$785.3MSold out, 15.1% → 0.0% of the portfolio−42,311,011 shares
- Veritiv Corp~$561.5MSold out, 10.8% → 0.0% of the portfolio−3,324,324 shares
- Alphabet~$124.3MCut, 9.7% → 9.1% of the portfolio−882,000 shares
- Liberty Global Plc~$123.2MSold out, 2.4% → 0.0% of the portfolio−7,194,276 shares
- Dollar Gen Corp New~$98.1MSold out, 1.9% → 0.0% of the portfolio−927,000 shares
- Qorvo~$89.3MSold out, 1.7% → 0.0% of the portfolio−935,612 shares
- Ss&C Technologies Hldgs Inc~$77.6MCut, 2.3% → 1.4% of the portfolio−1,270,091 shares
- Coinbase~$70.7MSold out, 1.4% → 0.0% of the portfolio−93,750,000 shares
- New Oriental Ed & Technology~$59.9MSold out, 1.1% → 0.0% of the portfolio−1,023,272 shares
- Liberty Media Corp Del~$44.3MCut, 1.2% → 0.6% of the portfolio−1,184,202 shares
Holdings
As of Dec 31, 2023; changes in shares since Sep 30, 2023.
| Holding | Value | ||||||||
|---|---|---|---|---|---|---|---|---|---|
| Liberty Global LtdCOM CL C · shares New | 17.2% | $788.7M | — | ||||||
| Viasat IncCOM · shares 0% · price +51.4% | 9.9% | $452.1M | +$153.5M | ||||||
| Liberty Media Corp DelCOM LBTY SRM S C · shares 0% · price +13.0% | 9.3% | $427.4M | +$49.3M | ||||||
| AlphabetCAP STK CL C · shares −23% · price +6.9% | 9.1% | $415.7M | +$26.8M | ||||||
| Fidelity Natl Information SvCOM · shares −8.6% · price +8.7% | 8.3% | $382.1M | +$30.5M | ||||||
| Willis Towers Watson Plc LtdSHS · shares 0% · price +15.4% | 8.2% | $375.2M | +$50.2M | ||||||
| Warner Bros Discovery IncCOM SER A · shares 0% · price +4.8% | 6.3% | $287.2M | +$13.1M | ||||||
| Clarivate PlcORD SHS · shares +13% · price +38.0% | 5.2% | $236.1M | +$57.4M | ||||||
| Liberty Media Corp DelCOM LBTY SRM S A · shares 0% · price +12.9% | 5.1% | $235.0M | +$26.9M | ||||||
| Crh PlcORD · shares 0% · price +26.4% | 5.0% | $231.4M | +$48.3M | ||||||
| Liberty Global LtdCOM CL A · shares New | 2.8% | $127.8M | — | ||||||
| Jazz Pharmaceuticals PlcSHS USD · shares +24% · price −5.0% | 2.2% | $102.5M | −$4.3M | ||||||
| Jacobs Solutions IncCOM · shares +49% · price −4.9% | 2.1% | $94.5M | −$3.3M | ||||||
| Theravance Biopharma IncCOM · shares 0% · price +30.2% | 1.8% | $83.4M | +$19.4M | ||||||
| Tower Semiconductor LtdSHS NEW · shares −4.9% · price +24.3% | 1.8% | $82.7M | +$16.2M | ||||||
| Liberty Media Corp DelCOM LBTY LIV S A · shares −4.0% · price +14.5% | 1.5% | $69.4M | +$8.8M | ||||||
| Ss&C Technologies Hldgs IncCOM · shares −55% · price +16.3% | 1.4% | $62.9M | +$8.8M | ||||||
| Gray Television IncCOM · shares 0% · price +29.5% | 0.73% | $33.7M | +$7.7M | ||||||
| Garrett Motion IncCOM · shares −50% · price +22.7% | 0.63% | $29.0M | +$5.4M | ||||||
| Liberty Media Corp DelCOM LBTY LIV S C · shares −62% · price +16.5% | 0.59% | $26.9M | +$3.8M | ||||||
| Herbalife LtdCOM SHS · shares −0.8% · price +9.1% | 0.56% | $25.6M | +$2.1M | ||||||
| Altice Usa IncCL A · shares 0% · price −0.6% | 0.34% | $15.5M | −$96,000 | ||||||
| Finch Therapeutics Group IncCOM NEW · shares 0% · price −30.4% | 0.01% | $243,000 | −$106,000 | ||||||
| Total 23 positions | 100% | $4.59B | +$520.2M |
Price is a stock's reported value over its shares at the quarter end. The estimated gain is the shares held at both quarter ends times the change in that price: shares bought or sold during the quarter add nothing, options are left out, and a stock split is read into the earlier share count and price.
What made money
From Q3 2023 to Q4 2023: 21 stocks held throughout, up $520.2M (+16.9%).
- Viasat Inc+$153.5M+51%
- Clarivate Plc+$57.4M+38%
- Willis Towers Watson Plc Ltd+$50.2M+15%
- Liberty Media Corp Del+$49.3M+13%
- Crh Plc+$48.3M+26%
- Altice Usa Inc−$96,000−1%
- Finch Therapeutics Group Inc−$106,000−30%
- Jacobs Solutions Inc−$3.3M−5%
- Jazz Pharmaceuticals Plc−$4.3M−5%
Estimated as in the holdings table: shares held at both quarter ends times the change in price; options left out.
Reported value by quarter
Pick a quarter to see what the fund held then.
Every quarter's filing
| Quarter | Reported value | Filing | |
|---|---|---|---|
| Q3 2026 | Nov 13, 2026 | $5.05B−7% | SEC ↗ |
| Q2 2026 | Aug 13, 2026 | $5.42B+6% | SEC ↗ |
| Q1 2026 | May 14, 2026 | $5.12B−3% | SEC ↗ |
| Q4 2025 | Feb 13, 2026 | $5.28B+10% | SEC ↗ |
| Q3 2025 | Nov 13, 2025 | $4.79B+16% | SEC ↗ |
| Q2 2025 | Aug 13, 2025 | $4.13B+18% | SEC ↗ |
| Q1 2025 | May 14, 2025 | $3.50B+2% | SEC ↗ |
| Q4 2024 | Feb 13, 2025 | $3.43B−2% | SEC ↗ |
| Q3 2024 | Nov 13, 2024 | $3.52B−3% | SEC ↗ |
| Q2 2024 | Aug 13, 2024 | $3.63B−0% | SEC ↗ |
| Q1 2024 | May 14, 2024 | $3.65B−20% | SEC ↗ |
| Q4 2023 | Feb 13, 2024 | $4.59B−12% | SEC ↗ |
| Q3 2023 | Nov 13, 2023 | $5.21B−7% | SEC ↗ |
| Q2 2023 | Aug 11, 2023 | $5.61B−4% | SEC ↗ |
| Q1 2023 | May 12, 2023 | $5.85B−5% | SEC ↗ |
| Q4 2022 | Feb 13, 2023 | $6.13B+6% | SEC ↗ |
| Q3 2022 | Nov 14, 2022 | $5.79B−14% | SEC ↗ |
| Q2 2022 | Aug 12, 2022 | $6.77B−27% | SEC ↗ |
| Q1 2022 | May 13, 2022 | $9.30B−8% | SEC ↗ |
| Q4 2021 | Feb 11, 2022 | $10.13B−7% | SEC ↗ |
| Q3 2021 | Nov 12, 2021 | $10.88B−12% | SEC ↗ |
| Q2 2021 | Aug 13, 2021 | $12.33B−2% | SEC ↗ |
| Q1 2021 | May 14, 2021 | $12.56B+16% | SEC ↗ |
| Q4 2020 | Feb 12, 2021 | $10.84B+17% | SEC ↗ |
| Q3 2020 | Nov 13, 2020 | $9.25B+15% | SEC ↗ |
| Q2 2020 | Aug 13, 2020 | $8.01B+18% | SEC ↗ |
| Q1 2020 | May 14, 2020 | $6.77B−25% | SEC ↗ |
| Q4 2019 | Feb 13, 2020 | $9.06B+3% | SEC ↗ |
| Q3 2019 | Nov 13, 2019 | $8.83B−20% | SEC ↗ |
| Q2 2019 | Aug 13, 2019 | $11.05B−7% | SEC ↗ |
| Q1 2019 | May 15, 2019 | $11.90B+3% | SEC ↗ |
| Q4 2018 | Feb 13, 2019 | $11.52B−12% | SEC ↗ |
| Q3 2018 | Nov 15, 2018 (amended) | $13.06B+14% | SEC ↗ |
| Q2 2018 | Aug 13, 2018 | $11.44B+10% | SEC ↗ |
| Q1 2018 | May 14, 2018 | $10.37B+3% | SEC ↗ |
| Q4 2017 | Feb 13, 2018 | $10.11B+26% | SEC ↗ |
| Q3 2017 | Nov 13, 2017 | $8.02B−8% | SEC ↗ |
| Q2 2017 | Aug 11, 2017 | $8.75B+3% | SEC ↗ |
| Q1 2017 | May 25, 2017 (amended) | $8.49B+11% | SEC ↗ |
| Q4 2016 | Feb 14, 2017 | $7.67B+9% | SEC ↗ |
| Q3 2016 | Nov 14, 2016 | $7.04B−4% | SEC ↗ |
| Q2 2016 | Aug 12, 2016 | $7.37B+6% | SEC ↗ |
| Q1 2016 | May 13, 2016 | $6.92B | SEC ↗ |